Scientific Seminar - Exploring New Drug Modalities From mAbs to Cell & Gene Therapies and Beyond
ANALIS ACADEMY - ONE DAY SEMINAR
Thank you for joining our seminar
Special thanks to your speaker for their valuable contributions
SCIENTIFIC SEMINAR
Are your workflows ready for next-generation drug development?
*ATTENTION - seats are limited, register now ! participation is free but registration is required.
Biopharma is evolving fast.
From monoclonal antibodies to cell & gene therapies,
staying ahead means mastering new tools, techniques, and platforms.
That’s why we’re thrilled to invite you to our
upcoming Analis Academy Scientific Seminar!
Discover how to optimize your lab for the future of therapeutics:
⚗️Cutting-edge platforms for automated
clone screening & EV characterization
🧫 New tools solving bottlenecks in mAb
& CGT workflows
🧪 Explore analytical advances, including in capillary
electrophoresis for complex drug formats
💡 Keynote insights from leading QC/QA professionals and academic biotech pioneers
🧭 Live demonstrations, networking, and expert one-on-ones with Analis & partners
This is your opportunity to benchmark your lab, explore next-gen analytical instruments, and gain exclusive access to use cases you won’t hear anywhere else.
🚀 Who Should Join?
- Biotech & Biopharma R&D leaders
- QC/QA managers in biologics & advanced therapy labs
- Process development engineers & lab managers
- Academia-industry translational researchers
- Scientists evaluating next-gen instrumentation
As places are limited and in order to reduce our environmental impact, if you are registered but unable to attend the seminar, please inform us as soon as possible by sending an email to RTE@ANALIS.BE - Thank you.
PROGRAM
08.45 - 09.45
Registration & Welcome Coffee
09.45 - 10.00
Welcome & Introduction : Transforming the Therapeutic Landscape
Analis Team
10.00 - 10.30
Overcoming Bottlenecks, Using an Automated Clone Screening System for Clone Selection in a mAb - Monoclonal Antibody - Workflow
The Cydem VT automated clone screening platform provides a high-throughput, integrated solution for Cell Line Development workflows. Automatization of critical screening steps improves experimental consistency and contributes to the acceleration of biopharmaceutical development timelines.
Anna Kress
Beckman Coulter Manager Applications Science
10.30 - 11.00
Standardizing Plasmid DNA Production: Inline Lysis Meets Single-Step Chromatography for CGT Breakthroughs
Plasmid DNA (pDNA) serves as a critical starting material to produce advanced therapy medicinal products (ATMPs) in the field of cell and gene therapy. The growing demand for pDNA requires the development of manufacturing processes that can meet aggressive timelines while maintaining cost-effectiveness. Here we present a robust single-use platform process that enables seamless scale-up from research and development (R&D) to good manufacturing practice (GMP) grade.
This process involves bacterial cell growth in fermenters, alkaline cell lysis, and a streamlined chromatographic step. A key aspect of this approach is the implementation of a controlled cell lysis step, ensuring the production of high-quality pDNA that complies with regulatory agency standards. Notably, this process achieves efficient purification and polishing with just a single chromatographic step, simplifying the manufacturing process as well as reducing costs.
We will provide an overview of the platform process and share results on the quality attributes obtained through its implementation. Our findings demonstrate the effectiveness of this approach in generating pDNA that meets quality requirements set by regulatory agencies.
Catalent - Director of Process and Analytical Development
11.00 - 11.15
Coffee Break
11.15 - 11.45
Empowering Breakthroughs in CGT with SCIEX Capillary Electrophoresis and Enhanced Detection
SCIEX Capillary Electrophoresis (CE) is a key technology in the analytical toolbox for Cell and Gene Therapy and other emerging modalities, offering high-resolution, reproducible analysis of complex biomolecules. This presentation will highlight critical applications in CGT workflows and introduce a newly launched detection system that enhances sensitivity and performance.
Marcus
Heinl
Sciex - Senior Field Application Specialist
11.45 - 12.15
How
Capillary Electrophoresis could be instrumental in the characterization of rAAVs - recombinant Adeno-Associated Viruses - in Gene Therapy
Prajakta Mulay
UCB - Scientist Biophysics method development in Gene therapy
12.15 - 13.15
Lunch & Networking
13.15 - 13.45
Extracellular Vesicles – Unlocking Biomedical Potential Through Advanced Separation and Characterization
EVs hold great promise for biomedical applications, but their complexity requires a robust technological toolbox for separation and characterization. My talk will highlight why these techniques are essential for advancing EV research, what they can reveal about EV biology, and how they can accelerate the translation of EVs into diagnostics and therapeutics.
An Hendrix
Principal investigator & Full professor, Laboratory of Experimental Cancer researcher at UGent - CRIG Group leader - Founder & President of the BESEV -
Scientific supervisor, CORE Extracellular Vesicles (UGent)
13.45 - 14.15
LNPs - Lipid Nanoparticles - the high potential drug delivery system of the future
Lipid Nanoparticles (LNPs) are revolutionizing drug delivery, from vaccines to gene therapies. In this presentation, we'll explore the milestones in their discovery and focus on their characterization including Flow Cytometry and Analytical Ultracentrifugation.
Lukas Bialkowski
BECKMAN COULTER - Bioprocessing market development Manager
14.15 - 14.30
Coffee Break
14.30 - 15.00
Integration of complex 2D and 3D cell brain models in Drug Discovery
Advancements in in vitro neuroscience have enabled the development of complex 2D monolayer and 3D organoid-based brain cell models for drug discovery. IPSC cultures allow medium to high-throughput screening and controlled manipulation of cellular phenotypes, while 3D models recapitulate cytoarchitecture, cell-cell interactions, and extracellular matrix dynamics. We describe protocols for generating region-specific brain organoids and co-culture systems, comparative transcriptomic and electrophysiological analyses. This integrative strategy accelerates CNS drug development by bridging the gap between in vitro modeling and clinical translation.
David Moreno
UCB -
Director of Cell Translational Sciences
15.00 - 15.30
Automation in Cell & Gene Therapy
Peter BRAUN
BECKMAN COULTER - Field-Project Manager EMEAI
15.30 - 16.00
Improving the accuracy of Western Blot Imaging for reliable results
Tristan Fromager
VILBER - Application Specialist - Regional Sales Manager
16.00- 16.30
Open discussion and closing session
Our great panel of Experts & Scientists
Already thanks to our speakers and partners.
Their expertise and insights will make this event a truly high-level and inspiring experience for all participants
Nuria Gomez Santos
Catalent
Director Process & Analytical Dev - CGT
PROGRAM
08.30 - 09.15
Registration & Welcome Coffee
LIVING TOMORROW
Indringingsweg 1, 1800 Vilvoorde
🚌 Easy access by public transport